Anebulo Pharmaceuticals GAAP EPS of -$0.05 beats by $0.07

* Anebulo Pharmaceuticals press release [https://seekingalpha.com/pr/20307273-anebulo-pharmaceuticals-reports-first-quarter-fiscal-year-2026-financial-results-and-recent] (ANEB [https://seekingalpha.com/symbol/ANEB]): Q1 GAAP EPS of -$0.05 beats by $0.07.
* Cash and cash equivalents were $10.4 million as of September 30, 2025. The Company also has access to an additional $3.0 million in cash through a Loan Agreement.

MORE ON ANEBULO PHARMACEUTICALS

* Seeking Alpha’s Quant Rating on Anebulo Pharmaceuticals [https://seekingalpha.com/symbol/ANEB/ratings/quant-ratings]
* Historical earnings data for Anebulo Pharmaceuticals [https://seekingalpha.com/symbol/ANEB/earnings]
* Financial information for Anebulo Pharmaceuticals [https://seekingalpha.com/symbol/ANEB/income-statement]